| Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview LE Adinolfi, R Nevola, G Lus, L Restivo, B Guerrera, C Romano, ... World journal of gastroenterology: WJG 21 (8), 2269, 2015 | 208 | 2015 |
| The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy R Galiero, PC Pafundi, R Nevola, L Rinaldi, C Acierno, A Caturano, ... Journal of diabetes research 2020, 2020 | 171 | 2020 |
| Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis S Petta, LE Adinolfi, AL Fracanzani, F Rini, R Caldarella, V Calvaruso, ... Journal of Hepatology 69 (1), 18-24, 2018 | 124 | 2018 |
| Efficacy and durability of multifactorial intervention on mortality and MACEs: A randomized clinical trial in type-2 diabetic kidney disease FC Sasso, PC Pafundi, V Simeon, L De Nicola, P Chiodini, R Galiero, ... Cardiovascular Diabetology 20, 1-12, 2021 | 109 | 2021 |
| Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study LE Adinolfi, S Petta, AL Fracanzani, C Coppola, V Narciso, R Nevola, ... Atherosclerosis 296, 40-47, 2020 | 96 | 2020 |
| Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients LE Adinolfi, R Nevola, B Guerrera, G D'Alterio, A Marrone, M Giordano, ... Journal of gastroenterology and hepatology 33 (7), 1379-1382, 2018 | 84 | 2018 |
| Chronic hepatitis C virus infection and depression LE Adinolfi, R Nevola, L Rinaldi, C Romano, M Giordano Clinics in liver disease 21 (3), 517-534, 2017 | 76 | 2017 |
| Metformin: An old drug against old age and associated morbidities T Salvatore, PC Pafundi, F Morgillo, R Di Liello, R Galiero, R Nevola, ... Diabetes Research and Clinical Practice 160, 108025, 2020 | 75 | 2020 |
| Risk of hepatocellular carcinoma after HCV clearance by direct-acting antivirals treatment predictive factors and role of epigenetics L Rinaldi, R Nevola, G Franci, A Perrella, G Corvino, A Marrone, ... Cancers 12 (6), 1351, 2020 | 70 | 2020 |
| Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: a prospective study LE Adinolfi, S Petta, AL Fracanzani, R Nevola, C Coppola, V Narciso, ... Diabetes, Obesity and Metabolism 22 (12), 2408-2416, 2020 | 68 | 2020 |
| Non-alcoholic fatty liver disease: From pathogenesis to clinical impact A Caturano, C Acierno, R Nevola, PC Pafundi, R Galiero, L Rinaldi, ... Processes 9 (1), 135, 2021 | 67 | 2021 |
| A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy C Mazzaro, L Quartuccio, LE Adinolfi, D Roccatello, G Pozzato, R Nevola, ... Viruses 13 (11), 2249, 2021 | 62 | 2021 |
| Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: A prospective multicentre study L Rinaldi, A Perrella, M Guarino, M De Luca, G Piai, N Coppola, ... Journal of Translational Medicine 17, 1-10, 2019 | 61 | 2019 |
| Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis L Rinaldi, F Nascimbeni, M Giordano, C Masetti, B Guerrera, A Amelia, ... World Journal of Gastroenterology 23 (8), 1458, 2017 | 57 | 2017 |
| Metformin lactic acidosis: Should we still be afraid? T Salvatore, PC Pafundi, R Marfella, C Sardu, L Rinaldi, L Monaco, ... Diabetes Research and Clinical Practice 157, 107879, 2019 | 55 | 2019 |
| Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study R Galiero, PC Pafundi, V Simeon, L Rinaldi, A Perrella, E Vetrano, ... PloS one 15 (12), e0243700, 2020 | 51 | 2020 |
| Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes FC Sasso, PC Pafundi, A Caturano, R Galiero, E Vetrano, R Nevola, ... Nutrition, Metabolism and Cardiovascular Diseases 31 (8), 2345-2353, 2021 | 46 | 2021 |
| Role of liver stiffness measurement in predicting HCC occurrence in direct-acting antivirals setting: a real-life experience L Rinaldi, M Guarino, A Perrella, PC Pafundi, G Valente, L Fontanella, ... Digestive diseases and sciences 64, 3013-3019, 2019 | 45 | 2019 |
| GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives R Nevola, R Epifani, S Imbriani, G Tortorella, C Aprea, R Galiero, ... International Journal of Molecular Sciences 24 (2), 1703, 2023 | 44 | 2023 |
| The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc … FC Sasso, V Simeon, R Galiero, A Caturano, L De Nicola, P Chiodini, ... Cardiovascular Diabetology 21 (1), 235, 2022 | 44 | 2022 |
